{
  "docId": "019de072-95ca-731a-9896-42747d7adc13",
  "docSlug": "33535989d43f8c82917f7de34c9c9d29",
  "documentTitle": "AbCellera | Investor Conference Presentation Deck | 25 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 25,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "balanced",
  "nDataPoints": 2,
  "notes": "The chart uses a combination of a line (investment/risk) and bars (cash flow) to visualize the drug development lifecycle.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-95ca-731a-9896-42747d7adc13/5",
  "deckHref": "/decks/019de072-95ca-731a-9896-42747d7adc13",
  "deckJsonHref": "/decks/019de072-95ca-731a-9896-42747d7adc13.json",
  "deckAnchorHref": "/decks/019de072-95ca-731a-9896-42747d7adc13#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.1,
        "x": 0.78,
        "y": 0.05
      },
      "kind": "callout",
      "text": "Peak sales ~ $1B",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4a02b216-fc2d-4a72-b78d-306dac69fa73",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.08,
        "x": 0.51,
        "y": 0.55
      },
      "kind": "callout",
      "text": "POS: >5%",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bac9147c-6e09-46bc-8929-e655d28e9ca2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.7,
        "x": 0.2,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Illustrative drug development investment profile",
      "attrs": null,
      "subkind": "waterfall-bridge",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "62c2e99b-0bbc-4ee1-a62a-328ee2146163",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.09,
        "x": 0.19,
        "y": 0.58
      },
      "kind": "subtitle",
      "text": "Technology intensive",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fb18bde5-5e2d-40bc-9705-a01e0d5a2595",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.09,
        "y": 0.12
      },
      "kind": "title",
      "text": "LONG. EXPENSIVE. RISKY.",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "34bb4205-7e24-4342-8ec9-7b697c968fcb",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Problem Statement Canvas",
      "slug": "problem-statement-canvas",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "88c648ba-a5d7-4042-a4ab-ffd618195a54",
      "evidence": "type: problem_statement",
      "confidence": 0.5
    },
    {
      "name": "Waterfall chart",
      "slug": "waterfall-chart",
      "agent": null,
      "layer": "slide",
      "matchId": "36fe8e54-a227-4f4c-bf6b-0761ce1334f2",
      "evidence": "chart/waterfall-bridge: Illustrative drug development investment profile",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "waterfall-bridge",
      "slug": null,
      "matchId": "70250a76-4daf-4f5b-861e-fea3054a0a3d",
      "evidence": "The chart visualizes the cumulative cash flow over time in a drug development lifecycle.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 5,
      "from": 1,
      "beatId": "708b8fc4-3b34-4473-9068-91034dec5617",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Situation & Context",
      "beatSlug": "consultants-gambit-situation-context",
      "evidence": "Slides 1-5 provide an overview of AbCellera and the challenges in therapeutic antibody drug development.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Setup",
      "parentBeatSlug": "setup"
    },
    {
      "to": 7,
      "from": 5,
      "beatId": "f31f54ac-8d3f-4ebb-88f0-031573b7e799",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Problem & Complication",
      "beatSlug": "consultants-gambit-problem-complication",
      "evidence": "Slides 5-7 highlight the complexity, expensiveness, and riskiness of the current process.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 7,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "a37b6b0e-3257-406e-9c64-6c6c51f980cf",
      "evidence": "Slides 5-7 imply that the current process is expensive and risky, making the cost of inaction high.",
      "position": 0,
      "objective": "What is the cost of not improving the current process?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}